Company / Profit Margin
Altimmune, Inc. Profit Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-214861.0%
FY2025
5-year range
-214861.0% / 124577.9%
FY2021-FY2025
Trend
-934.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -935% YoY in FY2025, a notable deviation from the 9-year average annual change of +473%.
Based on SEC 10-K filings.
-214861.0% in FY2025 with a 5-year CAGR of -214507.3%.
Declined from 124577.9% to -214861.0% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -212659.4pp
- 5-Year Change
- -214507.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 934.9% year-over-year.
- Peak profit margin was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -214861.0% | -934.9% |
| FY2024 | -20762.2% | -116.7% |
| FY2023 | 124577.9% | +5758.5% |
| FY2022 | -2201.6% | -267.4% |
| FY2021 | -599.2% | -69.4% |
| FY2020 | -353.7% | +6.7% |
| FY2019 | -379.2% | +12.3% |
| FY2018 | -432.3% | -26.2% |
| FY2017 | -342.6% | -106.4% |
| FY2011 | -166.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026